News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Shilpa Gupta: Honored and humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO
Photo from
May 29, 2024, 23:25

Shilpa Gupta: Honored and humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO

Shilpa Gupta shared a post on X:

“Honored and humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO Mon, Jun 3, 8 AM session co-chaired by Maite Bourlon, Suzanne Cole.”

Shilpa Gupta Shilpa Gupta

Source: Shilpa Gupta/X

Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.

ASCO ASCO24 cancer Maite Bourlon OncoDaily Oncology Shilpa Gupta Suzanne Cole
Special Coverage
Blog
Jan 17, 2025, 15:02
Cancer survivors across Europe face significant financial discrimination - European Cancer Organisation
Science
Jan 17, 2025, 14:52
Marcelo Negrao: Co-mutations and transcriptional signatures in non-small cell lung cancer patients
Blog
Jan 17, 2025, 14:44
Razelle Kurzrock: BRAF mutations are not one size fits all
Blog
Jan 17, 2025, 14:42
The Grand Opening Session of the 17th BGICC
Blog
Jan 17, 2025, 14:38
Elizabeth Ugwoma Awo-Ejeh: Cancer Turned My Life Upside Down
Science
Jan 17, 2025, 14:35
Elisa Agostinetto: The Preferable-Effect trial is now out
Blog
Jan 17, 2025, 13:20
Zainab Shinkafi-Bagudu: Cervical cancer is the first cancer we can eliminate for good
Blog
Jan 17, 2025, 13:16
Karen Knudsen: The Annual ACS Cancer Statistics Report has been released
Insight
Jan 17, 2025, 13:14
Rasha Aboelhassan: Proud to participate in ESMO Resilience Workshop 2025
Career
Jan 17, 2025, 13:12
Danielle Blake was appointed as Director of Global Oncology Communications, GU and Public Affairs for Johnson and Johnson
Insight
Jan 17, 2025, 12:59
Triparna Sen: SCLC augmenting immunotherapy and chemotherapy response
Science
Jan 17, 2025, 12:24
Myeloma Paper of the Day, January 17th, suggested by Robert Orlowski